Antiretroviral, integrase inhibitor (anti-hiv)labeled indicationshiv-1 infection, treatment: treatment of hiv-1 infection in combination with other antiretroviral agents in adult and pediatric patients weighing at least 30 kg, or in combination with rilpivirine in adults to replace the current antiretroviral regimen in those who are virologically suppressed (hiv-1 rna <50 copies per ml) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure or known substitutions associated with resistance to either antiretroviral agent.